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Summary The provision of care for patients with epilepsy in the UK is fragmented
and inadequate. Lack of support in the community, poor communication across the
primary—secondary care interface and inaccessibility of specialist services are con-
tributory factors. The inclusion of epilepsy as a quality marker in the new general
practitioner (GP) contract provides an opportunity to improve co-ordination of
services.
Prior to the acceptance of the New GP Contract in April 2004, the first part of this
audit aimed to (a) assess the documentation of the process of care of patients with
epilepsy in the city of Chester; and (b) provide GPs with a clinical resource to
facilitate review of patients and targeting of referrals to secondary care.
The case notes of 610 patients were scrutinised to identify the proportion (a)
receiving regular review, (b) in whom diagnosis was uncertain, (c) in documented
remission, (d) who were women of child-bearing age, (e) who were non-compliant
with treatment. A computerised template, including specific suggestions, was pro-
duced for every patient but responsibility for review remained with each GP. Re-audit
in 2 years was planned.
Two hundred and fifty (41%) had been seen by a GP in the previous year. One
hundred and sixteen (19%) had regular review arrangements. One hundred and thirty-
eight (22.6%) had shared care of whom 79 had seen their GP in previous year. Three
hundred and one (49%) had not seen any doctor concerning their epilepsy in the
previous year. Forty-three percent of adults who should be receiving shared care were
not doing so.
In 67 (11%) cases, there was diagnostic uncertainty. Only 178 (29.2%) patients were
in documented remission. One hundred and nine (17.8%) patients were women of
child-bearing age of whom 37 were receiving sodium valproate. In 84 (14%), there was
evidence of non-compliance.
Haphazard follow-up arrangements preclude review of diagnostic accuracy, esti-
mation of remission rate, assessment of adherence to prescribed treatment and
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teratogenic drugs. One cannot identify those patients who can be managed solely in
the community and those who merit reassessment in hospital clinics. Assuming these
findings are representative, primary and specialist secondary care face an enormous
task in reorganising services to ensure that all patients receive appropriate care. This
project describes a method of improving local co-ordination of patient care.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Epilepsy is the commonest chronic neurological dis-
order seen in primary care. All existing recommen-
dations, including the recent CSAG report,1
emphasise the role of the general practitioner
(GP) in the delivery of care to patients with epilepsy.
Indeed a key element of family practice, registra-
tion with a specific doctor, should ensure the con-
tinuity of that care.
While it may be difficult to directly relate the
process of care to overall patient outcome2 there
are powerful arguments for the regular review of,
and hazards of failure to review, individual patients.
This applies to both refractory epilepsy where the
diagnosis may be incorrect3 or where patients may
benefit from newer therapies4 and epilepsy in remis-
sion where statutory regulations may change5 and
where long-term treatment may not be necessary.6
Furthermore, all patients deserve to be informed
about new knowledge concerning the risks of treat-
ment, e.g. vigabatrin retinopathy,7 or fetal valpro-
ate syndrome.8
Historically review arrangements in primary
care have consistently been reported to be inade-
quate.1,9 While there are instances of effective
change,10,11 there has been no systematic attempt
by primary care to improve its contribution to the
quality of care of patients with epilepsy. This has
become a topical issue because of the putativeTable 1 Performance targets for epilepsy in new GP contr
Indicator
Records
EPILEPSY1. The practice can produce a register
of patients receiving drug treatment for epilepsy
Ongoing management
EPILEPSY 2. The percentage of patients of age 16
and over on drug treatment for epilepsy who have
a record of seizure frequency in the previous 15 month
EPILEPSY 3. The percentage of patients of age 16 and
over on drug treatment for epilepsy who have a record
of medication review in the previous 15 months
EPILEPSY 4. The percentage of patients of age 16
and over on drug treatment for epilepsy who have bee
convulsion-free for last 12 months recorded in last 15association between epilepsy-related death and
quality of care.12 Furthermore, the forthcoming
national service framework (NSF) for chronic dis-
ease will define standards of care for patients with
epilepsy and, indeed, the New GP Contract13 high-
lights four quality outcome measures each carrying
a minimum standard of attainment of 25%
(Table 1). For a practice to obtain maximum points,
and hence full remuneration, they must reach the
maximum threshold in each section documented
below.
In anticipation of the need to improve services
locally, the Chester City Primary Care Group (PCG)
appointed a GP to conduct a comprehensive audit of
the documented process of care of all patients with
epilepsy registered in 13 practices serving the city of
Chester, funded through SPREAD (Stimulating Pri-
mary Care Research and Development) monies. This
short report discusses the preliminary findings and
their implications.Methods
The practice records of 610 patients with a diagnosis
of epilepsy who were receiving repeat prescriptions
for anti-epileptic drugs (AEDs) were reviewed. Infor-
mation was collected using the paper notes and the
‘Vampvision’, ‘EMIS’ and ‘Torex’ GP computer oper-
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Figure 1 Variation in proportion of patients reviewed in
last year by practice.
Table 2 A calculation of the percentage of adults who
with drug-resistant epilepsy are receiving shared care
Number of patients receiving shared care 138
Number of patients under 16 year olds,
all under shared care
41
Total number of adults under shared care 97
Total number of adults 569
Assuming 30% of this adult population have
drug-resistant epilepsy, then proportion
who should be under shared care
(30% of 569)
171
Total therefore currently under
appropriate shared care (97/171)
57%In addition to simple demographic details, data
collected included documented evidence about (a)
diagnosis: when, by whom, and uncertainty. The
latter was assessed from correspondence at the time
of diagnosis, any doubt expressed in letters and the
auditor’s impression. (b) Follow-up arrangements;
date of last review, review frequency, whether nom-
inally receiving shared care. (c) Current condition:
whether in remission, prescribed treatment, compli-
ance. Compliance was evaluated on prescriptions
collected in the previous 12 months. It was intended
to collect information on seizure frequency, family
history, employment, driving, side effects, free pre-
scriptions and lifestyle issues. However, it became
quite clear that this information was poorly docu-
mented and would be unavailable.
The intervention comprised a consultant-led
tutorial on diagnosis and management, feedback
on specific cases in each practice and, crucially, a
computer-based template for each patient. This con-
tained demographic and clinical details including
results of investigations (EEG, imaging) and con-
cluded with patient categorisation and management
recommendations; diagnosis secure and manage-
ment appropriate–—annual review; epilepsy in
remission–—consider drug withdrawal; diagnostic
uncertainty, women of child-bearing age and refrac-
tory epilepsy–—consider referral for specialist assess-
ment. It was then the responsibility of the individual
GP/practice to review patients, document findings
and decide onwhether to intervene in the knowledge
that the notes would be re-audited in 2 years.
The time allocated to the project was one half day
a week during which time, on average, 20 case
recordswere reviewed.With time fordataprocessing
and preparing presentations for each practice the
first part of the audit cyclewas completed in approxi-
mately 15 months (December 2001—March 2003).
With the introduction of the template, a down-
load was taken at the time of audit as a baseline.
This will be repeated on a yearly basis to measure
any change which occurs. We plan to measure the
impact of the educational intervention but inter-
pretation of change may be confounded by the
impact of new contract (accepted June 2003, imple-
mented April 2004).
Statistics were analysed using Statsdirect comp-
uter software, using x2 and proportional x2 analysis.
Confidence levels (CL) are 95%.
Results
The 610 patients (324 male, 286 female) of all ages,
within a population of 99,924, indicate a prevalence
of 0.6%.Two hundred and fifty (41%) had seen their GP
concerning their epilepsy during the previous year.
Furthermore, review rates varied significantly
(range 7—79%) between practices (Fig. 1). Practice
2 is the author’s practice.
Of 138 (22%) patients nominally receiving shared
care, 59 had attended the hospital clinic only.
Therefore, 301 (49%) had not seen any doctor con-
cerning their epilepsy in the previous year.
While all 41 children of 16 years or younger were
attending paediatric clinics, only 97 adults had been
reviewed in hospital clinic. If we assume that 30% of
patients have a refractory condition, then a max-
imum of 97/171 (57%) of adults with drug-resistant
epilepsy who should be under shared care are
receiving this service (Table 2).
When considering patterns of follow-up in pri-
mary care, 116 (19%) (CL 5.9—28.9%) were being
reviewed regularly, i.e. at least yearly (Fig. 2), 84
(14%) were being reviewed opportunistically and
410 (67%) (CL 55.5—83.0%) had no formal review
pattern. Furthermore, 264 (43%) had not been
reviewed by the GP for more than 2 years.
Diagnostic doubt was expressed in 67 (11%) cases
(CL 6.2—13.4%). Uncertain diagnoses were more
likely to have been made by a general physician
(p = 0.0032) and less likely by a paediatrician
(p < 0.0001).
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Figure 2 Variance in rates of regular yearly review by
practice.
Figure 3 Documented percentages of patients in remis-
sion (no seizures >1 year) by practice.Only 178 (29%) (CL 20.0—36.6%) patients were in
documented remission, with a peak of 62% in one
practice (Fig. 3).
In 84 (14%) (CL 9.6—17.4) of the patients, there
was unequivocal evidence of non-compliance with
prescribed medication. This group was predomi-
nately male (m:f, 60:24) ( p = 0.0003). They were
no less likely to have uncertain diagnosis, to have
attended casualty or been admitted to hospital or to
have been reviewed in the last year. They were less
likely to be reviewed regularly (p = 0.017). Ten of
the men but no women had significant alcohol or
drug abuse in their histories.
There were 107 women of child-bearing age (16—
50 years) on treatment of which 37 were receivingTable 3 Summary of results
Total population 99,924





Reviewed by GP in last year 250
Reviewed by GP in last 2 years 96
Review greater than 2 years ago 264
Regular review 116
Patients not seen by any doctor in
previous 12 months re epilepsy
301
Estimated percentage of patients,





Women of child-bearing age
(16—50 years)
70
Women of child-bearing age
on valproate
37
Women of child-bearing age
on valproate with partial epilepsy
6
Documented remission 178
Admitted to A&E in last 2 years 43
Admitted to hospital in last 2 years 27sodium valproate, 6 of whom had evidence of partial
seizures.
All four patients on vigabatrin were under follow-
up by ophthalmologists.
A summary of the findings is illustrated in Table 3.Discussion
This project fulfilled its dual aims of quantifying the
documented process of care of patients with epi-
lepsy (PWE) across a city and providing every GP
with an individualised template for each patient to
facilitate review in the community and communica-
tion with secondary care. Our methods were well
received within participating practices and could be
widely replicated.
Audit findings
The most striking finding was the inadequate review
arrangements. No practice achieved a 90% review
rate while four practices failed to achieve the 25%
reviewrate,which is theminimumquality standard in
the proposed new contract. Our estimate that only
57% of adults with refractory epilepsy were receiving
shared care is a matter of particular concern.
The low remission rate (29%) is, probably, an
artefact of poor documentation. However, in the
absence of records we cannot be certain. There is
evidence that patients with poorly controlled epi-
lepsy may be reluctant to access services14 and poor
record keeping precludes accurate estimation of the
number of these patients who are not being seen.
The rate of diagnostic uncertainty (11%) is similar
to that described in other practice record reviews
but lower than that reported in studies where
patients have actually been assessed by specialists.3
The observed non-compliance rate (14%) was con-
sistent with previous reports.15 Men predominate,
16% of whom have documented drug or alcohol pro-
blems. These individuals were identified because of
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overlooked in a quick review appointment. The inclu-
sion of a ‘compliance’ field in the template should
promptGPs to consider this important aspect of care.
A direct consequence of failure to review is
doctors’ lack of awareness of patients’ knowledge
about the management of their condition. This is of
particular concern for young women taking poten-
tially teratogenic compounds. Studies in both pri-
mary16 and secondary care settings17 concur in
observing that many patients are uncertain about
the necessity for long-term therapy. This, in turn,
may contribute to poor or erratic compliance, which
is a risk factor for epilepsy-related sudden death.12
Theepilepsy-relateddeathaudit showedthereare
some 800 deaths per year from epilepsy in the UK,
some40%ofwhichmaybepreventable.12 It identified
the main problems with general practice as lack of
timely access to skilled specialists, sparse evidence
of structuredmanagement plans, triggers for referral
were sometimes missed and professional communi-
cation failures. This audit describes a mechanism for
overcoming these problems to improve local delivery
of care to people with epilepsy.
Intervention and change
Prior to this audit, only 1 from 13 practices was
systematically reviewing its patients with epilepsy.
Our unique intervention facilitates this process.
Every case record was thoroughly examined with
key features included in the template. It remains
the responsibility of individual GPs to assess their
patients and act accordingly. Neither the prospect
of re-audit nor the impending new contract compels
a GP to act. However, each patient’s template con-
cludes with a clear recommendation. Even those
doctors who choose to perform a cursory assessment
should be able to reach a logical decision about
management of each patient.Conclusion
If our findings are a true reflection of the process of
care of PWE in the community, then primary care
faces an enormous task if it wants to ensure that all
patients with epilepsy receive appropriate care in
future. The CSAG report1 recommends that each
large practice should have a lead GP with an interest
in epilepsy and these individuals could certainly
facilitate change locally. However, this project
has two distinct advantages over that proposal.
Firstly, there was co-operation between interested
representatives of primary and secondary care.
Secondly, the PCT-appointed GP has produced ameaningful disease register for his/her colleagues,
which facilitates the logical selection of patients for
continued management in the community or refer-
ral for reassessment in specialist clinics.
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